Systemic hypertensionAbnormal left ventricular filling: An early finding in mild to moderate systemic hypertension☆
References (27)
- et al.
Cardiac load and function in hypertension: ultrasonic and hemodynamic study
Am J Cardiol
(1979) - et al.
Patterns of left ventricular adaptation in borderline and mild essential hypertension: echocardiographic findings
Chest
(1981) - et al.
Normal left ventricular functional responses to upright bicycle exercise in hypertension (abstr)
Am J Cardiol
(1982) - et al.
Pathophysiologic assessment of hypertensive heart disease with echocardiography
Am J Cardiol
(1977) - et al.
Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study
Am J Cardiol
(1980) - et al.
A point score system tor the ECG diagnosis of left ventricular hypertrophy
Am Heart J
(1968) - et al.
Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index
Am J Cardiol
(1981) - et al.
Load-independent left ventricular dysfunction in hypertension: non-invasive detection (abstr)
Am J Cardiol
(1982) - et al.
Left ventricular compliance: mechanisms and clinical implications
Am J Cardiol
(1976) - et al.
Role of blood pressure in the development of congestive heart failure
N Engl J Med
(1972)
Left ventricular performance in patients with left ventricular hypertrophy caused by systemic hypertension
Br Heart J
Performance, wall dynamics and coronary function of the left ventricle in hypertensive heart disease
Clinical-physiologic correlations in the development of hypertensive heart disease
Circulation
Cited by (537)
Evaluation of Diastolic Function by Radionuclide Techniques
2020, Diastology: Clinical Approach to Heart Failure with Preserved Ejection FractionHypertension and Heart Failure
2019, Heart Failure ClinicsDiagnosis of Heart Failure With Preserved Ejection Fraction: Machine Learning of Spatiotemporal Variations in Left Ventricular Deformation
2018, Journal of the American Society of EchocardiographyCitation Excerpt :for velocity, (1) peak systolic amplitude, (2) time to peak systolic velocity, (3) the SD of segmental times to peak systolic velocity, and (4) peak early diastolic amplitude; for strain, (1) amplitude at end-systole, (2) when present, postsystolic deformation, and (3) the amplitude of diastolic strain at the end of the first third of the duration of diastole22-24; and for strain rate, (1) peak systolic amplitude, (2) peak early diastolic amplitude, (3) peak late diastolic amplitude during atrial contraction, (4) time to peak systolic strain rate, and (5) time to peak early diastolic strain rate.
Assessment of Left Ventricular Function by Layer-Specific Strain and Its Relationship to Structural Remodelling in Patients With Hypertension
2016, Canadian Journal of CardiologyThe impact of hypertension on diastolic left ventricular function, evaluated by quantitative ECG-gated myocardial perfusion SPECT
2015, Egyptian Journal of Radiology and Nuclear MedicineCitation Excerpt :Hypertension and cardiac ischemia are the most common causes of diastolic heart failure (2). Abnormalities of left ventricular (LV) diastolic filling have often been described in patients with hypertension (3–9), even in the absence of LV hypertrophy (4,7–9). Diastolic dysfunction in hypertensive patients is characterized primarily by impaired isovolumic relaxation (8,10).
Cardiac diastolic dysfunction predicts in-hospital mortality in acute ischemic stroke with atrial fibrillation
2014, Journal of the Neurological SciencesCitation Excerpt :Several factors may contribute to in-hospital mortality after cardioembolic stroke due to AF, such as larger infarcts, older age, and elevated plasma brain natriuretic peptide (BNP) level [5,6]. Diastolic dysfunction is caused by an abnormality of diastolic distensibility, filling, or relaxation of the left ventricle during diastole [7,8]. Heart failure related to diastolic dysfunction has a considerably high mortality even in patients with preserved left ventricular ejection fraction [9,10].
- ☆
This work was supported in part by Grant HL 28146 from the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
- ∗
Dr. Massie is a Clinical Investigator of the Veterans Administration Research Service.